BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9100609)

  • 1. Thyrotropin (TSH) receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription/translation system.
    Prentice L; Sanders JF; Perez M; Kato R; Sawicka J; Oda Y; Jaskolski D; Furmaniak J; Smith BR
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1288-92. PubMed ID: 9100609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor.
    Sanders J; Oda Y; Roberts S; Kiddie A; Richards T; Bolton J; McGrath V; Walters S; Jaskólski D; Furmaniak J; Smith BR
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3797-802. PubMed ID: 10523032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
    Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
    Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprecipitation analysis of pathological autoantibodies in Graves' patients' sera using biotinylated human thyrotropin receptor labeled with 125I-neutravidiny.
    Minich WB; Weymayer JD; Loos U
    Exp Clin Endocrinol Diabetes; 1999; 107(8):555-60. PubMed ID: 10612487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folding-dependent binding of thyrotropin (TSH) and TSH receptor autoantibodies to the murine TSH receptor ectodomain.
    Vlase H; Matsuoka N; Graves PN; Magnusson RP; Davies TF
    Endocrinology; 1997 Apr; 138(4):1658-66. PubMed ID: 9075728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human thyrotropin (TSH) receptor in a TSH binding inhibition assay for TSH receptor autoantibodies.
    Kakinuma A; Chazenbalk GD; Jaume JC; Rapoport B; McLachlan SM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2129-34. PubMed ID: 9215283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between thyrotropin receptor antibody bioactivity and inhibition of 125I-bovine thyrotropin binding.
    Wallaschofski H; Kaczmarek M; Miehle K; Hentschel B; Paschke R
    Thyroid; 2000 Oct; 10(10):897-907. PubMed ID: 11081256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies.
    Morgenthaler NG; Tremble J; Huang G; Scherbaum WA; McGregor AM; Banga JP
    J Clin Endocrinol Metab; 1996 Feb; 81(2):700-6. PubMed ID: 8636291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: purification and stabilization using chemical chaperones of the form reactive with Graves' autoantibodies.
    Chazenbalk GD; McLachlan SM; Pichurin P; Yan XM; Rapoport B
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1287-93. PubMed ID: 11238522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
    Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR
    Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
    McLachlan SM; Aliesky HA; Rapoport B
    Thyroid; 2019 Aug; 29(8):1138-1146. PubMed ID: 31184281
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding characteristics of antibodies to the TSH receptor.
    Oda Y; Sanders J; Roberts S; Maruyama M; Kato R; Perez M; Petersen VB; Wedlock N; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 1998 Apr; 20(2):233-44. PubMed ID: 9584838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function.
    Sanders J; Jeffreys J; Depraetere H; Evans M; Richards T; Kiddie A; Brereton K; Premawardhana LD; Chirgadze DY; Núñez Miguel R; Blundell TL; Furmaniak J; Rees Smith B
    Thyroid; 2004 Aug; 14(8):560-70. PubMed ID: 15320966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.
    Sanders J; Bolton J; Sanders P; Jeffreys J; Nakatake N; Richards T; Evans M; Kiddie A; Summerhayes S; Roberts E; Miguel RN; Furmaniak J; Smith BR
    Thyroid; 2006 Dec; 16(12):1195-206. PubMed ID: 17199429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
    Minich WB; Loos U
    Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
    Rapoport B; Aliesky HA; Chen CR; McLachlan SM
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.